Pfizer India (PFIZER) Q4 25/26 earnings summary

Executive summary

• Audited financial results for the year ended March 31, 2026, were approved, showing continued profitability and strong cash generation.

• Board recommended a final dividend of ₹75 per share (750%) for FY26, subject to AGM approval.

• No subsidiaries, associates, or joint ventures as of March 31, 2026.

Financial highlights

• Revenue from operations for FY26 was ₹2,519.65 crore, up from ₹2,281.35 crore year-over-year.

• Net profit for FY26 was ₹722.43 crore, compared to ₹767.60 crore in FY25.

• Total comprehensive income for FY26 was ₹726.27 crore, down from ₹768.34 crore in FY25.

• Earnings per share (EPS) for FY26 was ₹157.92, compared to ₹167.79 in FY25.

Outlook and guidance

• Dividend of ₹75 per share proposed, reflecting confidence in future cash flows.

• Company continues to monitor regulatory changes, including new labor codes, for future impact.